US4328183A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Blood cell typing and compatibility test procedure
Assignee: Icahn School of Medicine at Mount Sinai
•
Filing: 1980-07-18
•
Granted: 1982-05-04
•
Expires: 2000-07-18
Abstract
Abstract A solid-phase blood typing procedure is described based upon either aggluation or immune lysis. In this invention, a monolayer of cells is irreversibly bound to a solid matrix, and thereafter a serum containing antibodies is brought into contact with the bound cell layer. Immunoadsorption of antibodies by the bound cells occurs where the antigens of the cell membranes and the antibodies in the serum are complementary to each other. This antibody-sensitized monolayer of blood cells can either bind a second layer of blood cells carrying complementary antigen (solid-phase agglutination) or undergo lysis in the presence of serum lytic complement (solid-phase immune lysis). Carrying out these reactions with a monolayer of blood cells bound to a solid matrix allows quantitative evaluation of results by such standard instrumentable procedures as densitometric scanning, radioisotope counting, etc.
Inventors
- 👤 Richard E. Rosenfield
- 👤 Shaul Kochwa
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 16:20
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/80
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
66 words
A substrate for assaying red blood cell type or compatibility consisting essentially of (a) a light transmitting solid support membrane having a face to permit measurement of a surface layer applied thereon; and (b) a monolayer of red blood cells irreversibly adhered to said face, said red blood cells having been lysed to render the cells transparent, said cells carrying the antigenic determinants to be assayed.
Claim 2
Dependent Claim
66 words
A substrate for assaying red blood cell type or compatibility consisting essentially of (a) a light transmitting solid support membrane having a face to permit measurement of a surface layer applied thereon; and (b) a monolayer of red blood cells irreversibly adhered to said face, said red blood cells having been lysed to render the cells transparent, said cells carrying the antigenic determinants to be assayed.
Claim 3
Dependent Claim
25 words
A substrate according to claim 1 having, in addition, antibodies immunoadsorbed by the antigenic determinants to be assayed on said monolayer of red blood cells.
Claim 4
Dependent Claim
88 words
A substrate for assaying red blood cell type or compatibility consisting essentially of (a) a light transmitting solid support member having a face adapted to permit measurement of a surface layer applied thereon; (b) a layer applied to said face having reactive chemical groups thereon, effective to bind cells to said substrate; (c) a monolayer of red blood cells adhered to said face by said layer (b), said red blood cells having been lysed to render the cells transparent, said cells carrying the antigenic determinants to be assayed.
Claim 5
Dependent Claim
88 words
A substrate for assaying red blood cell type or compatibility consisting essentially of (a) a light transmitting solid support member having a face adapted to permit measurement of a surface layer applied thereon; (b) a layer applied to said face having reactive chemical groups thereon, effective to bind cells to said substrate; (c) a monolayer of red blood cells adhered to said face by said layer (b), said red blood cells having been lysed to render the cells transparent, said cells carrying the antigenic determinants to be assayed.
Claim 6
Dependent Claim
25 words
A substrate according to claim 3 having, in addition, antibodies immunoadsorbed by the antigenic determinants to be assayed on said monolayer of red blood cells.
Claim 7
Dependent Claim
71 words
A substrate for assaying cell type or compatibility consisting essentially of (a) a light transmitting solid support member of polystyrene with a face adapted to permit measurement of a surface layer thereon; (b) a layer of fibrinogen bound to said face of the polystyrene substrate; and (c) a layer of polylysine bound to said fibrinogen, said polylysine layer being capable of irreversibly binding a monolayer of cells to be assayed thereto.
Claim 8
Dependent Claim
71 words
A substrate for assaying cell type or compatibility consisting essentially of (a) a light transmitting solid support member of polystyrene with a face adapted to permit measurement of a surface layer thereon; (b) a layer of fibrinogen bound to said face of the polystyrene substrate; and (c) a layer of polylysine bound to said fibrinogen, said polylysine layer being capable of irreversibly binding a monolayer of cells to be assayed thereto.
Claim 9
Dependent Claim
28 words
A substrate according to claim 5 having a monolayer of cells irreversibly bound to said polylysine layer, said monolayer of cells carrying an antigenic determinant to be assayed.
References Cited (Backward Citations)
US3956477A
Cited
US3853467A
Cited
US3904367A
Cited
US4092116A
Cited
US3963441A
Cited
US3960491A
Cited
US3960489A
Cited
US4275053A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1985-05-03 | 1985-11-02 | 1986-05-04 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1989-05-03 | 1989-11-02 | 1990-05-04 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1993-05-03 | 1993-11-02 | 1994-05-04 | $7700.00 | Window Closed / Lapsed |